Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 33 (Search time: 0.001 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2021T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.Forbes, J.M.; McCarthy, D.A.; Kassianos, A.J.; Baskerville, T.; Fotheringham, A.K.; Giuliani, K.T.K.; Grivei, A.; Murphy, A.J.; Flynn, M.C.; Sullivan, M.A.; Chandrashekar, P.; Whiddett, R.; Radford, K.J.; Flemming, N.; Beard, S.S.; D'Silva, N.; Nisbet, J.; Morton, A.; Teasdale, S.; Russell, A.; et al.
2021Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantationGeorge, L.; Mahabal, G.; Mohanan, E.; Balasubramanian, P.; Peter, D.; Pulimood, S.; Lakshmi, K.; Jeyaseelan, L.; Abraham, A.; Srivastava, A.; Mathews, V.; George, B.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.
2022Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaKimura, S.; Montefiori, L.; Iacobucci, I.; Zhao, Y.; Gao, Q.; Paietta, E.M.; Haferlach, C.; Laird, A.D.; Mead, P.E.; Gu, Z.; Stock, W.; Litzow, M.R.; Rowe, J.M.; Luger, S.M.; Hunger, S.P.; Ryland, G.; Schmidt, B.M.; Ekert, P.G.; Oshlack, A.; Grimmond, S.; et al.
2022Impact of a standardised rapid response system on clinical outcomes of female patients: an interrupted time series approachChen, J.; Ou, L.; Hillman, K.; Parr, M.; Flabouris, A.; Green, M.
2022Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registryJames, S.; Perry, L.; Lowe, J.; Harris, M.; Craig, M.E.; Anderson, K.; Andrikopoulos, S.; Ambler, G.; Barrett, H.; Batch, J.; Bergman, P.; Cameron, F.; Colman, P.; Conwell, L.; Cotterill, A.; Cooper, C.; Couper, J.; Davis, E.; de Bock, M.; Donaghue, K.; et al.
2022Long‐term benzodiazepines and z‐drug prescribing in Australian general practice between 2011 and 2018: a national studyWoods, A.; Begum, M.; Gonzalez‐Chica, D.; Bernardo, C.; Hoon, E.; Stocks, N.
2020Ending rheumatic heart disease in Australia: the evidence for a new approachWyber, R.; Noonan, K.; Halkon, C.; Enkel, S.; Cannon, J.; Haynes, E.; Mitchell, A.G.; Bessarab, D.C.; Katzenellenbogen, J.M.; Bond-Smith, D.; Seth, R.; D'Antoine, H.; Ralph, A.P.; Bowen, A.C.; Brown, A.; Carapetis, J.R.; END RHD CRE Investigators Collaborators,
2020“Grumpy” or “furious”? arousal of emotion labels influences judgments of facial expressionsBarker, M.S.; Bidstrup, E.M.; Robinson, G.A.; Nelson, N.L.; Bos, P.A.